Abstract:Intratumoral hypoxia significantly constrains the susceptibility of solid tumors to oxygen-dependent photodynamic therapy (PDT), and effort to reverse such hypoxia has achieved limited success to date. Herein, we developed a novel engineered bacterial system capable of targeting hypoxic tumor tissues and efficiently mediating the photodynamic treatment of these tumors. For this system, we genetically engineered Escherichia coli to express catalase, after which we explored an electrostatic adsorption approach to link black phosphorus quantum dots (BPQDs) to the surface of these bacteria, thereby generating an engineered E. coli/BPQDs (EB) system. Following intravenous injection, EB was able to target hypoxic tumor tissues. Subsequent 660 nm laser irradiation drove EB to generate reactive oxygen species (ROS) and destroy the membranes of these bacteria, leading to the release of catalase that subsequently degrades hydrogen peroxide to yield oxygen. Increased oxygen levels alleviate intratumoral hypoxia, thereby enhancing BPQD-mediated photodynamic therapy. This system was able to efficiently kill tumor cells in vivo, exhibiting good therapeutic efficacy. In summary, this study is the first to report the utilization of engineered bacteria to facilitate PDT, and our results highlight new avenues for BPQD-mediated cancer treatment.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c20254?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c20254</a>.Materials, methods, oxygen generation in 3% H2O2 solution after different bacteria lysis treatments as measured by a dissolved oxygen meter (Figure S1); AFM image of BPQDs (Figure S2); absorbance spectra of EB before and after rotation (Figure S3); height profiles of the BPQDs (Figure S4); CLSM photo of pure E. coli modified with DSPE-PEG-Cy5 (Figure S5); DCFH-DA fluorescence intensity (Figure S6); viability of E. coli survival rate (Figure S7); blood biochemistry data of kidney function markers: CRE and BUN (Figures S8 and S9); blood biochemistry data of liver function markers: ALT, ALP, and AST (Figure S10); histopathologic examination of tissues (Figure S11); and DCFH-DA fluorescence intensity (Figure S12) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c20254/suppl_file/am0c20254_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Self-Propelled and Near-Infrared-Phototaxic Photosynthetic Bacteria As Photothermal Agents for Hypoxia-Targeted Cancer Therapy

Nanoparticles Conjugated with Bacteria Targeting Tumors for Precision Imaging and Therapy.

Active-oxygenating hollow Prussian blue nanosystems loaded with biomacromolecules for photodynamic/photothermal therapy of cancer and alleviating hypoxic tumors

Cyanobacteria-based near-infrared light-excited self-supplying oxygen system for enhanced photodynamic therapy of hypoxic tumors

Near-infrared photosensitizers adaptive to tumor hypoxic microenvironment for synergistic photothermal-photodynamic and immunotherapy

Self‐Mineralized Photothermal Bacteria Hybridizing with Mitochondria‐Targeted Metal–Organic Frameworks for Augmenting Photothermal Tumor Therapy

Bio-inspired self-assembled bacteriochlorin nanoparticles for superior visualization and photothermal ablation of tumors

Multi-functional nanosonosensitizer-engineered bacteria to overcome tumor hypoxia for enhanced sonodynamic therapy

Photosynthetic Microorganisms-Based Biophotothermal Therapy with Enhanced Immune Response.

Novel Engineered Bacterium/Black Phosphorus Quantum Dot Hybrid System for Hypoxic Tumor Targeting and Efficient Photodynamic Therapy

Photothermal Responsive Singlet Oxygen Nanocarriers for Hypoxic Cancer Cell Ablation

Photosynthetic Cyanobacteria‐Hybridized Black Phosphorus Nanosheets for Enhanced Tumor Photodynamic Therapy

Hyperbaric oxygen enhances tumor penetration and accumulation of engineered bacteria for synergistic photothermal immunotherapy

Light-triggered photosynthetic engineered bacteria for enhanced-photodynamic therapy by relieving tumor hypoxic microenvironment

NIR-absorbing Superoxide Radical and Hyperthermia Photogenerator Via Twisted Donor-Acceptor-donor Molecular Rotation for Hypoxic Tumor Eradication

Near-infrared photoactivatable three-in-one nanoagents to aggravate hypoxia and enable amplified photo-chemotherapy

Living Therapeutics for Synergistic Hydrogen‐Photothermal Cancer Treatment by Photosynthetic Bacteria

Hypoxia-responsive Near Infrared Thioxanthene-Hemicyanine Nanoparticle for Multimodal Imaging-Guided Photothermal/photodynamic Therapy

A two-pronged strategy to alleviate tumor hypoxia and potentiate photodynamic therapy by mild hyperthermia

Upconversion Nanoparticles Hybridized Cyanobacterial Cells for Near‐Infrared Mediated Photosynthesis and Enhanced Photodynamic Therapy

Hypoxia-triggered single molecule probe for high-contrast NIR II/PA tumor imaging and robust photothermal therapy